Matthew E Rossheim
Overview
Explore the profile of Matthew E Rossheim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen-Sankey J, LoParco C, La Capria K, Meng S, Mazzeo R, Vijayakumar N, et al.
medRxiv
. 2025 Feb;
PMID: 39973983
Introduction: The 2018 Farm Bill unintentionally allowed the proliferation of derived intoxicating cannabis vape products (DICVPs), raising concerns about associated health risks. To inform public health prevention efforts, this study...
2.
Olsson S, Sekhon V, LoParco C, Yockey R, Greene K, Henry D, et al.
Subst Use Misuse
. 2025 Feb;
:1-7.
PMID: 39901444
Background: Following the United States (U.S.) Federal Agriculture Improvement Act of 2018, many retailers began selling intoxicating cannabis products, including Delta-8 tetrahydrocannabinol (THC) as "hemp," claiming that it provided a...
3.
LoParco C, Cui Y, McCready D, Rossheim M, Chen-Sankey J, Howlader A, et al.
Subst Use Addctn J
. 2025 Feb;
:29767342251313860.
PMID: 39891561
Background: Given the substantial expansion of the US cannabis market and the impact of cannabis advertising exposure on use, cannabis marketing surveillance is needed to inform regulations and protect consumers....
4.
Rossheim M, Treffers R, Sparks A, Sparks M, Tillett K, LoParco C, et al.
J Stud Alcohol Drugs
. 2024 Nov;
PMID: 39589808
No abstract available.
5.
Rossheim M, Tillett K, Vasilev V, LoParco C, Agwuncha T, Sekhon V, et al.
Alcohol Clin Exp Res (Hoboken)
. 2024 Nov;
49(1):226-233.
PMID: 39552029
Background: Alcohol pricing policies can reduce population-level alcohol consumption. To inform these policies, it is essential to understand the price per standard alcoholic drink of the least expensive brands. This...
6.
Wang S, Rossheim M, Walters S, Nandy R, Northeim K
Am J Drug Alcohol Abuse
. 2024 Oct;
50(5):690-702.
PMID: 39405524
Amid the national opioid epidemic, it is important to assess trends in opioid prescriptions. Long-acting opioids (LAOs) are of particular interest as they are among the most intensely misused prescription...
7.
LoParco C, Rossheim M, Cui Y, McCready D, Romm K, Wang Y, et al.
Addict Behav
. 2024 Sep;
160:108180.
PMID: 39332229
Aims: To characterize derived psychoactive cannabis product (DPCP) perceptions and use among US young adults. Methods: We analyzed 2023 survey data among 4,031 young adults (ages 18-34), comprising ∼ 50 ...
8.
LoParco C, Tillett K, Chen-Sankey J, Berg C, Rossheim M
Addiction
. 2024 Sep;
120(1):189-190.
PMID: 39327681
No abstract available.
9.
Rossheim M, LoParco C, Tillett K, Yockey R, Lin H, Berg C
Am J Public Health
. 2024 Sep;
114(11):1188-1190.
PMID: 39236279
No abstract available.
10.
LoParco C, Bone C, Berg C, Rossheim M, Peeri N, Tillett K, et al.
J Racial Ethn Health Disparities
. 2024 Aug;
PMID: 39196491
Background: Kratom is federally unregulated and is marketed as an opioid alternative despite limited evidence and known negative effects. Disparities in associations between opioid and kratom use may be partly...